SCHEMBL11144521

SCHEMBL11144521

Cc1cccc(Cl)c1NC(=O)/N=C1/SCC(=O)N1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ LCK P06239 8/20 0.40
▸ MAPK14 Q16539 6/20 0.40
▸ MAPK13 O15264 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ HCK P08631 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ MAPK12 P53778 1/20 0.40
▸ MAPK11 Q15759 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ PDK3 Q15120 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11141779 1.00 GRM5 (0.42) GRM5MEN1KMT2AGAALCK
SCHEMBL11155555 0.93 GRM5 (0.46) GRM5MEN1KMT2AGAANPC1
SCHEMBL11155554 0.93 GRM5 (0.46) GRM5MEN1KMT2AGAANPC1
SCHEMBL11147165 0.92 KMT2A (0.46) GRM5MEN1KMT2AGAAALDH1A1
SCHEMBL11147166 0.92 KMT2A (0.46) GRM5MEN1KMT2AGAAALDH1A1
SCHEMBL11146311 0.87 GRM5 (0.42) GRM5MEN1KMT2AGAANPC1
SCHEMBL11145628 0.87 GRM5 (0.42) GRM5MEN1KMT2AGAANPC1
SCHEMBL11150764 0.85 L3MBTL1 (0.55) KMT2AGAALCKMAPK14MAPK13
SCHEMBL11148292 0.85 L3MBTL1 (0.41) GRM5MEN1KMT2AGAAPDK1
SCHEMBL11144761 0.85 ALDH1A1 (0.44) GRM5MEN1KMT2ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback